D-0668-2016 Class I Terminated
FDA drug recall D-0668-2016 was initiated by Hospira Inc. on Jan 5, 2016 and is designated Class I. Reason for recall: Labeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which scans in as heparin sodium. The recall status is terminated (terminated Sep 28, 2017). Affected quantity: 213,600 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 24, 2016
- Initiation Date
- Jan 5, 2016
- Termination Date
- Sep 28, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 213,600 bags
Product description
Magnesium Sulfate in Water for Injection, (0.325 mEq Mg++/mL) 40 mg/mL, 2 g Total, 50 mL Single-Dose Container bag, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6729-24.
Reason for recall
Labeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which scans in as heparin sodium.
Distribution pattern
Nationwide
Code information
Lot: 53-113-JT, Exp 1NOV2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0668-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.